← All compounds
metabolite0 listings
ITPP
ITPP (Myo-inositol trispyrophosphate)
Oxygen-delivery compound. Endurance research.
Endurance researchHypoxia researchCardiovascular research
/ research index
The research base
Research Maturity
★★★☆☆
3/5 — Volume of studies
Evidence Strength
★★★☆☆
3/5 — Quality of evidence
Researched for endurance research.
/ mechanism of action
How it works
Increases hemoglobin oxygen release to tissues; studied for hypoxia and endurance.
/ research dosing
Common research protocols
Range
Research-stage
Frequency
Protocol-dependent
Route
Oral or injection (research)
Cycle
Ongoing research use
Research notes
Allosteric effector of hemoglobin enhancing tissue oxygenation. Investigated for heart failure and performance.
References
FOR RESEARCH USE ONLY. Doses listed are compiled from published research literature, FDA-approved drug labels, and well-documented research community practice. Not medical advice.
/ standalone use
As a solo compound
Standalone oral research compound.
/ side effects
What to know
Generally well-tolerated; see research notes.
/ timeline
Realistic expectations
Weeks to months
FOR RESEARCH USE ONLY. ITPP is intended for laboratory research and not for human consumption.